References - Lauzardo, M; Ashkin, D. Phthisiology at the dawn of the new century. Chest. 2000;117:1455–1473. doi: 10.1378/chest.117.5.1455. [PubMed]
- Maher, D; Chalet, P; Spinaci, S; Harries, AD. Treatment of tuberculosis: guidelines for national programmes. Geneva: WHO. 1997.
- Bucher, HC; Griffith, LE; Guyatt, GH, et al. Isoniazid prophylaxis for tuberculosis with in HIV infection: Meta-analysis of randomized controlled trials. AIDS. 1999;13:501–507. doi: 10.1097/00002030-199903110-00009. [PubMed]
- Daley, CL; Small, PM; Schecter, GF; Schoolnik, GK; McAdam, RA; Jacobs, WR, Jr; Hopewell, PC. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficieny virus: an analysis using restriction-fragment-length-polymorphisms. N Engl J Med. 1992;326:231–235. [PubMed]
- Odhiambo, JA; Borgdorff, MW; Kiambih, FM, et al. Tuberculosis and HIV the epidemic: increasing annual risk of infection in Kenya. 1986 – 1996. Am J Public Health. 1999;89:1078–1082. [PubMed]
- Dye, C; Scheele, S; Dolin, P; Pathania, V; Raviglione, MC. Global burden of tuberculosis. Estimated incidence, prevalence, and mortality by country. JAMA. 1999;282:677–686. doi: 10.1001/jama.282.7.677. [PubMed]
- Cantwell, MF; Binkin, NJ. Tuberculosis in sub-Saharan Africa: A regional assessment of the impact of the human immunodeficiency virus and National Tuberculosis Control Program quality. Tuber Lung Dis. 1997;77:220–225. doi: 10.1016/S0962-8479(96)90004-0. [PubMed]
- Puustinen, K; Marjamaki, M; Rastogi, N; Sola, C; Filliol, I; Ruuti, P; Holmstrom, P; Viljanen, MK; Soini, H. Characterization of Finnish Mycobacterium tuberculosis isolates by spoligotyping. J Clin Microbiol. 2003;41:1525–1528. doi: 10.1128/JCM.41.4.1525-1528.2003. [PubMed]
- van Crevel, R; Nelwan, RH; de Lenne, W, et al. Mycobacterium tuberculosis Beijing genotype associate with febrile response to treatment. Emerg Infect Dis. 2001;7:880–883. [PubMed]
- Kamerbeek, JL; Schouls, L; Kolk, A; van Agterveld, M; van Soolingen, D; Kuijper, S; Bunschoten, A; Molhuizen, H; Shaw, R; Goyal, M, et al. Simultaneous detection of and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997;35:907–914. [PubMed]
- Kremer, K; van Soolingen, D; Frothingham, R; Haas, WH; Hermans, PWM; Martin, C; Palittapongarnpim, P; Plikaytis, BB; Riley, LW; Yakrus, MA, et al. Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis strains: interlaboratory study of discriminatory power and reproducibility. J Clin Microbiol. 1999;37:2618.
- Chan, MY; Borgdorff, MW; Yip, CW; de Haas, PE; Wong, WS; Kam, KM; van Soolingen, D. Seventy percent of the M. tuberculosis isolates in Hong Kong represent the Beijing genotype. Epidemiol Infect. 2001;127:169–171. doi: 10.1017/S0950268801005659. [PubMed]
- Frieden, TR; Sherman, LF; Maw, KL; Fujiwara, PI; Crawford, JT; Nivin, B; Sharp, V; Hewlett, D, Jr; Brudney, K; Alland, D, et al. A multi-institutional outbreak of highly drug-resistant tuberculosis: Epidemiology and clinical outcome. JAMA. 1996;276:1229–1235. doi: 10.1001/jama.276.15.1229. [PubMed]
- Morris, S; Bai, GH; Suffys, P; Portillo-Gomez, L; Fairchok, M; Rouse, D. Molecular mechanisms of multi drug resistance in clinical isolates of Mycobacterium tuberculosis. J Infect Dis. 1995;171:954–960. [PubMed]
- Stoeckle, MY; Guan, L; Riegler, N; Weitzman, I; Kreiswirth, B; Komblum, J; Laraque, F; Riley, LW. Catalase peroxidase gene sequences in Isoniazid-sensitive and resistance strains of Mycobacterium tuberculosis from New York City. J Infect Dis. 1993;168:1063–1065. [PubMed]
- Zhang, Y; Heym, B; Allen, B; Young, D; Cole, S. The catalase peroxidase gene and Isoniazid resistance of Mycobacterium tuberculosis. Nature. 1992;358:591–593. doi: 10.1038/358591a0. [PubMed]
- Banerjee, A; Dubnau, E; Quemard, A; Balasubramanian, V; Um, KS; Wilson, T; Collins, D; de Lisle, G; Jacobs, WR., Jr inhA, a gene encoding a target for Isoniazid and Ethionamide in Mycobacterium tuberculosis. Science. 1994;263:227–230. doi: 10.1126/science.8284673. [PubMed]
- Heym, B; Honore, N; Truffot-Pernot, C; Banerjee, A; Schurra, C; Jacobs, WR, Jr; van Embden, JD; Grosset, JH; Cole, ST. Implication of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Lancet. 1994;344:293–298. doi: 10.1016/S0140-6736(94)91338-2. [PubMed]
- van der zanden, AGM; Te Koppele-Vije, ; Vijaya Bhanu, N; van Soolingen, D; Schouls, LM. Use of DNA extracts from Ziehl Neelsen-stained slides for molecular detection of Rifampicin resistance and spoligotyping of Mycobacterium tuberculosis. J Clin Microbiol. 2003;41:1101–1108. doi: 10.1128/JCM.41.3.1101-1108.2003. [PubMed]
- Brudey, K; Driscoll, JR; Rigouts, L; Prodinger, WM; Gori, A; Al-Hajoj, SAM; Allix, C; Aristimuno, L; Arora, J; Baumanis, V, et al. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiology. 2006;6 [PubMed]
- Hirsh, AE; Tsolaki, AG; DeRiemer, K; Feldman, MW; Small, PM. Stable association between strains of Mycobacterium tuberculosis and their human host populations. Proc Natl Acad Sci USA. 2004;101:4871–4876. doi: 10.1073/pnas.0305627101. [PubMed]
- McHugh, TD; Batt, SL; Shorten, RJ; Gosling, RD; Uiso, L; Gillespie, SH. Mycobacterium tuberculosis lineage: A naming of the parts. Tuberculosis. 2005;85:127–136. doi: 10.1016/j.tube.2004.06.002. [PubMed]
- Eldholm, V; Matee, M; Mfinanga, SGM; Heun, M; Dahle, UR. A first insight into the genetic diversity of Mycobacterium tuberculosis in Dar es Salaam, Tanzania, assessed by spoligotyping. BMC Microbiol. 2006;6:76. doi: 10.1186/1471-2180-6-76. [PubMed]
- Anh, DD; Borgdorff, MW; Van, LN; Lan, NTN; Gorkom, Tvan; Soolingen, Dvan; Kremer, K, et al. "Beijing " genotype emerging in Vietnam. Imerg Infect Dis. 2000;6:302–305.
- Niemann, S; Rusch-Gerdes, S; Joloba, ML; Whalen, CC; Guwatudde, D; Ellner, JJ; Eisenach, K; Fumokong, N; Johnson, LJ; Aisu, T, et al. Mycobacterium africanum subtype II is associated with two distinct genotypes and is a major cause of human tuberculosis in Kampala, Uganda. J Clin Microbiol. 2002;40:3398–3405. doi: 10.1128/JCM.40.9.3398-3405.2002. [PubMed]
- Diguimbaye, C; Hilty, M; Ngandolo, R; Mahamat, HH; Pfyffer, GE; Baggi, F; Tanner, M; Schelling, E; Zinsstag, J. Molecular characterization and drug resistance testing of Mycobacterium tuberculosis isolates from Chad. J Clin Microbiol. 2006;44:1575–1577. doi: 10.1128/JCM.44.4.1575-1577.2006. [PubMed]
- Kuaban, C; Bercion, R; Noeske, J; Cunin, P; Nkamsse, P; Ngo, NS. Anti-tuberculosis drug resistance in the West province of Cameroon. Int J Tuberc Lung Dis. 2000;4:356–360. [PubMed]
- Streicher, EM; Warren, RM; Kewley, C; Simpson, J; Rastogi, N; Sola, C; van der Spuy, GD; van Helden, PD; Victor, TC. Genotypic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from rural districts of Western Cape province of South Africa. J Clin Microbiol. 2004;42:891–894. doi: 10.1128/JCM.42.2.891-894.2004. [PubMed]
- Tudo, G; Gonzalez, J; Obama, R; Rodriguez, JM; Franco, JR; Espasa, M; Simarro, PR; Escaramis, G; Ascaso, C; Garcia, A, et al. Study of resistance to anti-tuberculosis drugs in five districts of Equatorial Guinea: rates, risk factors, genotyping of gene mutations and molecular epidemiology. Int J Tuberc Lung Dis. 2004;8:15–22. [PubMed]
- Espinal, MA; Laszlo, A; Simonsen, L; Boulahbal, F; Kim, SJ; Reniero, A; Hoffner, S; Rieder, HL; Binkin, NJ; Dye, C, et al. Global trends in resistance to antituberculosis drugs. World Health Organisation – International Union Against Tuberculosis and Lung Disease Working Group on anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med. 2001;344:1294–1303. doi: 10.1056/NEJM200104263441706. [PubMed]
- Ministry of Health The United Republic of Tanzania. manual of the national tuberculosis and leprosy programme in Tanzania. 2003.
- Sanders, M; Van Deun, A; Ntakirutimana, D, et al. Rifampicin monoresistant Mycobacterium tuberculosis in Bujumbura; results of drug resistance survey. Int J Tuberc Lung Dis. 2006;10:178–183. [PubMed]
- van Rie, A; Warren, RM; Beyers, N; Gie, RP; Classen, CN; Richardson, M, et al. Transmission of a multidrug-resistant Mycobacterium tuberculosis strain resembling "strain W" among noninstitutionalized, human immunodeficiency virus -seronegative patients. J Infect Dis. 1999;180:1608–1615. doi: 10.1086/315054. [PubMed]
- Murray, JF. The white plague: down and out, or up and coming? Am Rev Respir Dis. 1989;140:1788–1795. [PubMed]
- Elliot, AM; Halwiindi, B; Hayes, RJ; Luo, N; Mwinga, AG; Tembo, G; Machiels, L; Steenbergen, G; Pobee, JO; Nunn, P. The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia. Trans R Soc Trop Med Hyg. 1995;89:78–82. doi: 10.1016/0035-9203(95)90668-1. [PubMed]
- Harries, AD; Nyangulu, DS; Kang'ombe, C; Ndalama, D; Glynn, JR; Banda, H; Wirima, JJ; Salaniponi, FM; Maher, D; Nunn, P. Treatment outcome of an unselected cohort of tuberculosis patients in relation to human immunodeficiency virus serostatus in Zomba hospital, Malawi. Trans R Soc Trop Med Hyg. 1998;92:343–347. doi: 10.1016/S0035-9203(98)91036-7. [PubMed]
- Reed, MB; Domenech, P; Manca, C; Su, H; Barczak, AK; Kreiswirth, BN; Kaplan, G; Barry, CE. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature. 2004;431:84–87. doi: 10.1038/nature02837. [PubMed]
- Kent, PT; Kubica, GP. Public health mycobacteriology – a guide for level III laboratory. U.S. Department of Health and Human Services, Washington, D.C.; 1985.
- van der zanden, AGM; Hoentjen, AH; Heilmann, FG; Weltevreden, LM; Schouls, LM; van Embden, JD. Simultaneous detection of and strain differentiation of Mycobacterium tuberculosis complex in paraffin wax embedded tissues and stained microsopic preparations. Mol Pathol. 1998;51:209–214. [PubMed]
- Kwok, S; Higuchi, R. Avoiding false positive with PCR. Nature. 1989;339:237–238. doi: 10.1038/339237a0. [PubMed]
- Longo, MC; Berninger, MS; Hartley, JL. Use of Uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. Gene. 1990;93:125–128. doi: 10.1016/0378-1119(90)90145-H. [PubMed]
- International Spoligotype Database of the Institut Pasteur de Guadeloupe. http://www.pasteur-guadeloupe.fr/tb/
- Balows. Manual of clinical microbiology. 5. 1991. Phenotypic DST with proportional method; pp. 304–340.
|